The emergence of YMDD mutants precedes biochemical flare by 19 weeks in lamivudine-treated chronic hepatitis B patients: an opportunity for therapy reevaluation by P.H.C. França, H.S.M. Coelho, C.E. Brandão, J.A. Segadas, R.F. Quintaes, F.J. Carrilho, S. Ono-Nita, A.A. Mattos, C. Tovo, V.S. Gouvea, E. Sablon, B.O.M. Vanderborght

Get full text